Iroquois Capital Management LLC 13D and 13G filings for Synthetic Biologics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-23 4:42 pm Sale | 2021-12-31 | 13G | Synthetic Biologics, Inc. SYN | Iroquois Capital Management LLC | 230,870 1.920% | -30,000 (-11.50%) | Filing |
| 2021-02-22 09:45 am Unchanged | 2020-12-31 | 13G | Synthetic Biologics, Inc. SYN | Iroquois Capital Management LLC | 260,870 9.990% | 0 (Unchanged) | Filing |
| 2020-02-14 10:36 am Unchanged | 2019-12-31 | 13G | Synthetic Biologics, Inc. SYN | Iroquois Capital Management LLC | 260,870 9.990% | 0 (Unchanged) | Filing |